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Abstract
Aim: To determine whether Compound 49b, a novel beta-adrenergic receptor agonist, can prevent increased
inflammation and apoptosis in mice after exposure to ocular blast.
Methods: Eyes of C57/BL6 mice were exposed to a blast of air from a paintball gun at 26 psi (≈0.18 MPa). Eyes
were collected 4 hours, 24 hours, and 72 hours after blast exposure. In a subset of mice, Compound 49b eyedrops
(1 mM) were applied within 4 hours, 24 hours, or 72 hours of the blast. Three days after blast exposure, all mice
were sacrificed. One eye was used to measure levels of retinal proteins (TNFα, IL-1β, Bax, BcL-xL, caspase 3, and
cytochrome C). The other eye was used for TUNEL labeling of apoptotic cells, which were co-labeled with NeuN to
stain for retinal ganglion cells.
Results: We found that ocular exposure to 26 psi air pressure led to a significant increase in levels of apoptotic and
inflammatory mediators within 4 hours, which lasted throughout the period investigated. When Compound 49b
was applied within 4 hours or 24 hours of blast injury, levels of apoptotic and inflammatory mediators were
significantly reduced. Application of Compound 49b within 72 hours of blast injury reduced levels of inflammatory
mediators, but not to untreated levels.
Conclusions: Ocular blast injury produces a significant increase in levels of key inflammatory and apoptotic markers
in the retina as early as 4 hours after blast exposure. These levels are significantly reduced if a beta-adrenergic
receptor agonist is applied within 24 hours of blast exposure. Data suggest that local application of beta-adrenergic
receptor agonists may be beneficial to reduce inflammation and apoptosis.
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Background
Ocular trauma constitutes one of the most common causes
of unilateral morbidity and blindness in the world today
[1]. During recent wars, many ocular injuries have been
caused by explosions with fragmentary munitions; they are
the fourth most common injury in U.S. Operation Iraqi
Freedom [2]. Owing to improvements in body protective
gear, the rates of combat-based morbidity and mortality
have decreased, while the number of ocular injuries has
increased (from 0.57% during the American Civil War
to 13% in U.S. Operation Desert Storm) [1,3]. While
all soldiers agree that eyewear is important, many are
noncompliant because the eyewear becomes foggy, is
bulky, or is unstylish [2]. In addition to the compliance
issue, the ability of eye protective gear is, at present, lim-
ited. Even with improved eye protective wear, eye injuries
still occur in 24% of blast injury cases. Thus, despite de-
velopments in military protective wear, the blast produced
by many improvised explosive devices is associated with
closed, as well as open-globe, injuries from fragmentary
munitions. Owing to other life-threatening injuries that
may occur after exposure to blasts from such devices,
ocular repair and treatment is often delayed for as long
as 3 or 4 days after the initial injury [2,3].
To better understand the nature of eye damage after
exposure to ocular blast, a good model needs to be de-
veloped. Unfortunately, before this year, few such models
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have existed. Whole-body models of blast injury have been
used to investigate the effects of blasts on major organ
systems [4] or to the brain [5]. These studies demon-
strated that Kevlar protection is effective in protecting
internal organs from injury, but that the brain and eyes
are still affected by the blast wave. Furthermore, al-
though work in the brain-blast model [6] demonstrated
damage to the visual tracts of the brain, the retina itself
was not fully examined. To better mimic ocular trauma
and allow for thorough characterization of retinal responses,
a new model has been developed using an air blast from a
paintball gun as the primary inducer of trauma [7]. Using
this model, Hines-Beard et al. demonstrated with high-
resolution optical coherence topography, gross pathology,
and optokinetics that a pressure of 23 to 26 psi (≈0.16 to
0.18 ≈MPa) produced a number of anterior and a few
posterior ocular injuries [7]. In this study of various blast
pressures, the authors found only one eye to have changes
to the retina, choroid, or retinal pigmented epithelium
after exposure to 26 psi. This corresponds well with previ-
ous studies in veterans [8]. Despite the lack of gross path-
ology, it is probable that the posterior eye is still altered
after blast exposure, and will produce increased levels of
inflammatory or apoptotic markers. To investigate changes
in retinal inflammatory and apoptotic mediators after
blast, we employed the same model as described in [7]
and measured levels of key proteins within 4 hours, 1 day,
and 3 days after blast exposure.
Furthermore, we have previously reported that β-
adrenergic receptor agonists, particularly a novel drug,
Compound 49b, have anti-apoptotic and anti-inflammatory
properties in retinal endothelial cells and in a diabetic
retinopathy model [9,10]. Compound 49b is based struc-
turally on isoproterenol, with chemical modifications to
increase its ocular potency as a topical treatment. The
chemical properties of Compound 49b are listed in Table 1.
The chemical structure of Compound 49b is patent
pending [11]. Our hypothesis in this study was that top-
ical application of Compound 49b within 24 hours of blast
injury would prevent blast-induced increases in inflamma-
tory mediators and apoptotic markers.
Methods
Mice
C57/BL6 mice were purchased from Charles River
(Wilmington, MA) at 2 months of age. Mice were ex-
posed to an ocular blast of 26 psi (≈0.18 MPa) to both
eyes using an air blast from a paintball gun [7]. The
pressures were measured and analyzed using Labview
software (National Instruments, Austin, TX). All animal
experiments were approved by the Institutional Animal
Care and Use Committee at the University of Tennessee
Health Science Center (Protocol #2079).
Both eyes of the mice were exposed to the ocular blast.
In one subset of mice, eyes were collected at 4 hours
post-blast, 24 hours post-blast, 72-hours post-blast, or at
72 hours without exposure to the blast. In a second sub-
set of mice, both eyes were blasted; however, a novel β-
adrenergic receptor agonist, Compound 49b (1 mM),
was applied topically within 4 hours, 24 hours, or 72
hours post-blast. The mice treated with Compound 49b
received Compound 49b treatment daily for up to 3
days. For example, for the 4-hour treatment group, the
mice received the first treatment within 4 hours post-
blast, then further treatments at 24 hours, 48 hours, and
72 hours post-blast (for a total of four treatments), while
the mice who were treated 72-hours post-blast only re-
ceived one treatment of Compound 49b prior to sacri-
fice. All mice treated with Compound 49b were
sacrificed three days post-blast. Ten mice were used at
each time point for all experiments.
Western blotting
At the appropriate time after the blast or Compound
49b treatments, one eye was used for protein analyses.
For Western blot analyses, retinal lysates were collected
into lysis buffer containing protease and phosphatase in-
hibitors and scraped into the tubes. Retinal extracts were
prepared by sonication. Equal amounts of protein from
the cell or tissue extracts were separated on pre-cast
tris-glycine gel (Invitrogen, Carlsbad, CA), blotted onto
a nitrocellulose membrane. After blocking in Tris-
buffered saline with Tween 20 (10 mM Tris–HCl buffer,
pH 8.0, 150 mM NaCl, 0.1% Tween 20) and 5% (w/v)
BSA, the membrane was treated with appropriate pri-
mary antibodies followed by incubation with secondary
antibodies labeled with horseradish peroxidase. Antigen-
antibody complexes were detected using a chemilumin-
escence reagent kit (Thermo Scientific). Primary antibodies
used were cytochrome C, Bax, and BcL-xL, NFkB, and
phosphorylated NFkB (all purchased from Cell Signaling,
Danvers, MA).
ELISA
A cleaved caspase 3 ELISA (Cell Signaling, Danvers, MA)
was used to measure levels of the active apoptotic markers
Table 1 Compound 49b
Molecular formula (in salt) C19H26ClNO6
Molecular weight (in salt) 399.87
Molecular formula (in neutral) C19H25NO6
Molecular weight (in neutral) 363.40
Octanol-water partition coefficient, log P 1.92
pKa ≈ 9
Octanol-water partition coefficient (log P) of Compound 49b is a measure of
its lipophilicity. Log P was calculated using ChemDraw Ultra version 8.0
(CambridgeSoft Corporation, Cambridge, MA).
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in whole retinal lysates. TNFα and IL-1β protein concen-
trations were measured using TNFα and IL-1β ELISAs,
respectively (ThermoFisher, Pittsburgh, PA). All ELISAs
were done according to the manufacturer’s instructions
with equal protein loaded into all wells.
Terminal deoxynucleotidyl transferase mediated dUTP
nick end labeling assay (TUNEL)
TUNEL was done on 10 μm cryosections of mouse retina
according to the manufacturer’s instructions using the
ApopTag-FITC kit (Millipore, Bilerica, MA) to localize
apoptotic cells in the retina at the various time points.
TUNEL positive cells were co-localized with NeuN anti-
body (Abcam), to demonstrate which cell types were
undergoing apoptosis.
Statistics
For all analyses, all experiments were done in triplicate.
Data are presented as mean ± standard error of the mean,
with statistical analyses using Kruskal-Wallis nonpara-
metric testing, followed by Dunn’s test.
Results
Blast exposure increases TNFα and IL-1β levels in retinal
lysates as early as 4 hours; this is mitigated by topical
Compound 49b
Since a thorough analysis of inflammatory and apoptotic
markers after blast exposure has not been reported, we
chose to investigate levels of TNFα and IL-1β, both key
proteins in other retinal diseases [12,13], within 4 hours,
24 hours, and 72 hours of exposure to 26 psi (≈0.18 MPa)
blast. We found that protein levels of both TNFα and
IL-1β were significantly increased within 4 hours of
blast exposure and remained elevated for the 72 hours
investigated (Figure 1). Additionally, we found that if
topical Compound 49b (1 mM) was applied within 4,
24, or 72 hours of the blast exposure, the β-adrenergic
receptor agonist could significantly reduce levels of both
TNFα and IL-1β (Figure 1). In the case of TNFα, treat-
ments within 4 or 24 hours of blast exposure could
return TNFα levels to a level not significantly differ-
ent from that for an eye that had not been exposed
to a blast.
Compound 49b reduces apoptotic proteins after
exposure to ocular blast
Because activation of inflammatory mediators often leads
to apoptosis [14,15], we evaluated levels of key apoptotic
proteins (Bax, cytochrome C, cleaved caspase 3) and an
anti-apoptotic marker (BcL-xL) after exposure to blast
alone or blast + Compound 49b at 4, 24, and 72 hours
post-blast (Figure 2). Blast exposure significantly increased
levels of pro-apoptotic markers and reduced levels of
BcL-xL. Compound 49b effectively reduced Bax and cyto-
chrome C levels and increased BcL-xL levels if applied
within 24 hours of blast. Compound 49b was effective
in reducing cleaved caspase 3 at all times investigated.
Taken together, this demonstrates that the blast induces
a strong apoptotic response, which is mitigated by appli-
cation of Compound 49b, best applied within 1 day of
blast exposure.
Ocular blast induces apoptosis of cells in ganglion cell layer
To visualize cells undergoing apoptosis after ocular blast
exposure, we performed TUNEL labeling of retina sec-
tions with co-localization with NeuN to label retinal gan-
glion cells after blast with or without Compound 49b
(Figure 3). It is clear that apoptosis is occurring in cells
of the ganglion cell layer as early as 4 hours after blast,
and becoming more pronounced over the 72 hours of
Figure 1 ELISA results for TNFα (left) and IL-1β (right) in mouse retina without exposure to blast (NT) or with exposure to blast for 4,
24, or 72 hours with or without Compound 49b for 4, 24, or 72 hours. *P < 0.05 vs. NT. #P < 0.05 vs. blast only at the same time point. N = 5
mice for each group. NT, no treatment.
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the study. Compound 49b reduces this apoptosis; this
finding is in agreement with the apoptotic protein
marker analyses.
Discussion
Ocular trauma is a leading cause of vision loss for sol-
diers, as well as the general public [3,16]. Unfortunately,
little is known of the effects of exposure of blast pres-
sure to the retina. Using the same model as used for this
work, Hines-Beard only observed changes to the retinal
pigmented epithelium in one eye [7]. While the morph-
ology of the retina might not have changed, protein ex-
pression within the retina would probably have become
activated and initiated changes, to be manifested in the
Figure 2 Western blot results for key pro-apoptotic proteins (Cytochrome C and Bax—top) and anti-apoptotic protein BcL-xL (bottom left).
ELISA results for cleaved caspase 3. *P < 0.05 vs. NT. #P < 0.05 vs. blast only at the same time point. N = 5 mice for each group. NT, no treatment.
Figure 3 TUNEL labeling and NeuN (retinal ganglion cell marker). (A) untreated mice, (B) 4 hours post-blast, (C) 4 hours post-blast with
Compound 49b, (D) 24 hours post-blast, (E) 24 hours post-blast with Compound 49b, (F) 72 hours post-blast, and (G) 72 hours post-blast with
Compound 49b. TUNEL labeling is green; NeuN staining is red. Scale bar is 50 μm.
Jiang et al. Journal of Neuroinflammation 2013, 10:96 Page 4 of 6
http://www.jneuroinflammation.com/content/10/1/96
morphology in the future. We found that within 4 hours
of exposure to an ocular blast, a significant increase in
levels of key inflammatory and apoptotic markers could
be observed. This was associated with increased TUNEL
labeling within the cells of the ganglion cell layer, which
became more pronounced with additional exposure time
of inflammatory and apoptotic markers.
Little is known on cellular changes following exposure
to ocular blast or in closed-globe ocular injuries. For
most ocular trauma studies, work has focused on corneal
burns or trauma. However, since it is likely that other
ocular targets are affected following exposure to the
blast, literature on cellular changes in these targets may
be relevant. Mice receiving a chemical burn to the cor-
nea had significantly increased levels of TNFα and IL-1β,
as well as macrophage migration inhibitory factor [17]. In
a review of animal models of retinal injury, retinal gan-
glion cell apoptosis and inflammation are key points of
discussion [18]. While the majority of the discussion in
the work by Blanch et al. [18] was focused on axotomy of
retinal ganglion cells or the optic nerve, the findings are
similar to our observations after exposure to ocular blast,
with increased levels of inflammatory mediators and apop-
totic rates. In a subsequent paper on retinal changes in a
closed-globe injury model, these authors describe in-
creased TUNEL labeling and apoptosis of photoreceptors
in the retina, after injury had been induced by firing an air
gun pellet or ball bearing into mice’s eyes [19]. In this
model involving projectiles into the eye, photoreceptor
apoptosis and necrosis were observed, but specific
apoptotic proteins or inflammatory proteins were not
investigated. It is clear that further work on the cellular
changes in the retina after injury is warranted.
Our findings of increased inflammatory and apoptotic
markers after exposure to ocular blast agree with work
from corneal burns or other closed-globe models. A re-
cent report on British soldiers in Iraq and Afghanistan
investigated ocular injuries, with the primary injury be-
ing trauma from exposure to a foreign body. In that
work, the authors concluded that treatments could be
safely delayed for 24 hours to allow for treatment of more
life-threatening injuries [20]. Our results with Compound
49b eyedrop therapy support this conclusion, demon-
strating that Compound 49b can reduce both inflamma-
tory mediators and apoptotic markers for up to 72 hours
after blast exposure. We have previously reported that
Compound 49b is effective in reducing levels of TNFα
and apoptotic proteins in diabetic animals up to 6 months,
when applied daily [9]. Isoproterenol was equally effective
at reducing levels of TNFα and apoptosis, but it had un-
wanted cardiovascular effects [10]. Future work will focus
on the mechanisms by which Compound 49b can reduce
inflammatory and apoptotic markers induced by ocular
blast exposure.
Conclusions
Exposure to ocular blast, similar to closed-globe injuries
observed in soldiers, increases key inflammatory and
apoptotic proteins for up to 72 hours after blast exposure.
This response occurred primarily in the cells of the
ganglion cell layer of the retina. Compound 49b, a novel
β-adrenergic receptor agonist, could mitigate the increased
inflammatory and apoptotic markers, with optimal re-
sponses observed when treatment was initiated within
at least 24 hours of blast exposure. Since Compound
49b has little observed toxicity and can be administered
in an eyedrop, it may offer a new therapy to protect the
retina of soldiers after exposure to explosive devices in
the combat field.
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